An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene
about
PAX3-FOXO1 fusion gene in rhabdomyosarcomaRegulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegationProgressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagusEmbryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targetingA new generation of pPRIG-based retroviral vectors.Animal models of soft-tissue sarcoma.Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesisEwing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1Molecular approaches to sarcoma therapy.Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma.Molecular and cellular biology of rhabdomyosarcoma.A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.RETRACTED: Association of ataxia telangiectasia mutated (ATM) gene mutation/deletion with rhabdomyosarcoma.Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.Regulation of Schwann cell differentiation and proliferation by the Pax-3 transcription factor.
P2860
Q24646520-A7F6283B-8C82-4632-B64C-A50328908EB4Q24671965-62D98960-F6EE-4086-9358-AF419E50A61BQ28214540-09E2C5C5-29D3-41FA-BA56-442081CF514BQ30426842-7BC3BF24-9A8F-4741-91B5-E2B9F929F4D8Q33308292-5B150289-453D-4A98-A307-A68647610054Q34098113-29C1A352-3EA4-4DA6-96CC-E9C6E3094401Q34405491-54037516-3558-4E5B-844C-682C19518A8AQ35005937-160F6B4E-BC66-4C71-923E-F71DEC9AD19EQ35057457-494A1205-D8D4-4AAF-AF53-B2D09498D4E2Q36647855-1687F413-A5BD-4AC1-89C6-20FE7F0117C8Q37180948-2C858A98-6A3E-44AC-AB03-914AB7A53188Q37395824-5EAB035E-A686-4889-A16A-BC83961A5A59Q37630588-0E83846D-6F9B-4D69-90F6-B231E6D03EEAQ38083828-72556189-0EC2-4332-B808-CAE8719419CCQ38355978-4D1D4C65-D4DA-41AC-B588-BA2B49CC9EC9Q39389232-A3ADF774-E96D-472A-8605-9E1EC4DC302FQ47162540-E4083D59-B6BA-4668-B991-4A1071ACD282
P2860
An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
An engineered PAX3-KRAB transc ...... endogenous PAX3-FKHR oncogene
@ast
An engineered PAX3-KRAB transc ...... endogenous PAX3-FKHR oncogene
@en
type
label
An engineered PAX3-KRAB transc ...... endogenous PAX3-FKHR oncogene
@ast
An engineered PAX3-KRAB transc ...... endogenous PAX3-FKHR oncogene
@en
prefLabel
An engineered PAX3-KRAB transc ...... endogenous PAX3-FKHR oncogene
@ast
An engineered PAX3-KRAB transc ...... endogenous PAX3-FKHR oncogene
@en
P2093
P2860
P1476
An engineered PAX3-KRAB transc ...... endogenous PAX3-FKHR oncogene
@en
P2093
F J Rauscher
J R Friedman
K Ayyanathan
W J Fredericks
P2860
P304
P356
10.1128/MCB.20.14.5019-5031.2000
P407
P577
2000-07-01T00:00:00Z